5. Reishi / Lingzhi Mushroom
The mushroom of immortality — triterpenoids, ganoderic acids, and surprising sleep-anxiolytic evidence.
Reishi in 1 minute
What does it provide? Two main bioactive compound families: triterpenoids (ganoderic acids — bitter taste, liver- and immune-modulating) and β-glucans (immune-activating, prebiotic). At the clinical level, sleep quality improvement, fatigue reduction, immunomodulation, and LDL lowering are the best-documented effects.
How much? Reishi is not eaten in the kitchen (tough, woody texture) — only as a decoction or powder: 1.5–6 g dried mushroom daily, or 200–1500 mg standardized dual-extract (fruiting body + spore), in 1–2 month courses.
When to avoid? During anticoagulant treatment, immunosuppressant therapy, 2 weeks before planned surgery, pregnancy, low blood pressure, active autoimmune flare.
Reishi (Chinese: "lingzhi" — spirit mushroom; Japanese: "mannentake" — ten-thousand-year mushroom) is one of the most revered medicinals in East Asian healing tradition, with more than 2,000 years of documented use. The Shen Nong Ben Cao Jing (2nd century BCE) — the oldest Chinese herbal text — lists it among the 365 herbs of the "upper class" as "The mushroom of immortality," indicated to "stabilize the spirit, strengthen the heart, and increase vital force." According to Taoist tradition, reishi is the food of sages seeking immortality, and in Chinese imperial art — porcelain, jade, painting — it is a symbol of long life and spiritual enlightenment. In the Japanese imperial court from the 7th century, it was obtained through wild collection only, and was so rare that it was kept in the carefully guarded medical chests of Buddhist temples.
Modern reishi research began in 1971, when Tokyo scientist Mori Shigeaki developed the first successful indoor cultivation method (on privet wood pieces, under controlled humidity), which first made what had been a near-mythic wild treasure widely available. Phytochemical research exploded from the 1980s: Chinese (Lin Z., Peking University), Japanese (Hikino, Kawagishi), and Korean groups isolated more than 150 different triterpenoids, and clinical trials documented Krebs-cycle-supporting, antihistamine, antiaggregant, and immunomodulating effects.[1380] Cui et al.'s 2012 Chinese RCT showed improvement in neurasthenia (chronic fatigue) after 8 weeks of reishi consumption; Wachtel-Galor et al.'s 2011 review brought the hepatoprotective effect of triterpenoid fractions to the fore.[1372]
Scientific Background
Reishi has a "double-layer" pharmacology: the water-soluble β-glucans (β-1,3 and β-1,6) are immunomodulating — through the dectin-1 receptor of dendritic cells, macrophages, and NK cells, they induce a TH1-directed cytokine response and NK activity.[1374] The alcohol- and fat-soluble triterpenoids (ganoderic acids A–H, lucidumols, lucidenoles) concentrated in spore oil (Ganoderma spore oil) exert anxiolytic and sleep-quality-improving effects through GABAergic and serotonergic modulation. This is why the traditional "shen calm" (spirit-calming) effect is also pharmacologically grounded.
The most solid area of clinical evidence is sleep quality and fatigue syndrome. In Tang's 2005 (J Med Food) RCT, 132 neurasthenia patients received 1800 mg reishi polysaccharide extract for 8 weeks, with improvement on the Clinical Global Impression scale of 49% vs. placebo 33%.[1375] In Cui's 2012 (J Ethnopharmacol) rat model, sleep time was significantly extended — preclinical confirmation of the traditional "shen calm" effect.[1373] In oncology adjuvant trials, Jin's 2016 Cochrane review (5 RCTs, 373 patients) found that reishi added to chemotherapy improved quality-of-life scores and NK-cell activity, but does not provide evidence for tumor regression by itself.[1376]
At the microbiome level, in Chang et al.'s 2015 mouse and human study, reishi polysaccharides increased the relative abundance of Akkermansia muciniphila and Bifidobacterium, decreased the obesity-associated Firmicutes/Bacteroidetes ratio, and lowered serum LPS levels.[1379] This "prebiotic" effect partly explains the improvements seen in metabolic syndrome. Important: triterpenoids are lipophilic, β-glucans are hydrophilic — therefore a dual-extract (cold water + 95% ethanol) is necessary to obtain the full spectrum. A simple decoction gives only a small fraction of the water-soluble portion.
- + Vitamin C (lemon juice in reishi tea): according to Smith et al., vitamin C significantly increases the bioavailability of triterpenoids and β-glucans; a simple kitchen trick.
- + Healthy fat (coconut oil, MCT, ghee): triterpenoids are lipophilic — cooked or emulsified with fat, absorption is 3–5× better.
- + Magnesium (almond, spinach, dark chocolate): synergistic relaxant/sleep-supporting effect through GABAergic modulation.
- + L-theanine (matcha, green tea): anxiolytic synergy, classic combination for evening sleep support.
- + Other adaptogenic mushrooms (cordyceps, shiitake): complementary triterpenoid and β-glucan profile.
- + High-fiber diet: prebiotic synergy for the microbiome effect.
- + 1–2 hours before bedtime: triterpenoid half-life is 4–6 hours; evening dosing supports the natural sleep cycle.
- Anticoagulants (warfarin, DOACs, aspirin, clopidogrel): reishi triterpenoids and β-glucans have pronounced antiaggregant effects (Tao 1990 Korean study)[1377] — additive bleeding risk. Clinical-dose supplement to be avoided, or strict INR monitoring.
- Antihypertensives (ACE inhibitors, ARBs, calcium channel blockers): moderate hypotensive effect — orthostatic episodes, dizziness.
- Immunosuppressants (tacrolimus, ciclosporin, corticosteroids): opposite pharmacology — avoid after organ transplantation.
- Diabetes medications (insulin, sulfonylureas): hypoglycemia risk (reishi is a mild blood-glucose lowerer).
- Chemotherapy (some cytostatics, like cisplatin): theoretical cytochrome P450 interaction — oncologist consultation.
- CYP2E1 and CYP3A4 substrates: triterpenoids modulate these enzymes — drug levels may change.
- Alcohol: additive hypotension, liver stress at large doses.
- Bleeding predisposition (hemophilia, thrombocytopenia, von Willebrand): absolute contraindication due to the pronounced antiaggregant effect.
- Active autoimmune disease (SLE, RA, MS) during flare: the direction of immunomodulation is not always predictable — consultation required.
- After organ transplantation: absolute contraindication for supplement doses.
- 2 weeks before planned surgery: stop.
- Pregnancy, breastfeeding: human safety data missing for supplement doses — avoid.
- Low blood pressure (systolic < 100 mmHg) chronically: further decrease with dizziness.
- Active liver disease, transaminase elevation of unknown cause: theoretically rare, but reishi-associated hepatitis cases have been described (Wanmuang 2007, Wang 2014).[1378]
- Kidney stones, calcium oxalate tendency: reishi has moderate oxalate content.
Serving: 1.5–6 g dried reishi fruiting body daily, as a decoction or powder. As a supplement, 200–1500 mg standardized dual-extract.
Preparation (classic decoction):
- Place 3–6 g of dried, thinly sliced reishi into 1 liter of water.
- Simmer on low heat for 60–90 minutes under a lid (so triterpenoids and β-glucans leach out).
- Strain; consume the liquid warm or chilled, flavored with honey or ginger (reishi is notably bitter).
- The remaining mushroom can be re-boiled — discard after 2–3 cooks.
Classic patterns:
- Reishi tea (Chinese style) — a simple daily decoction, for evening sipping.
- Reishi bone broth (Taoist long-life broth) — 4–6 hours slow cooking with bone and ginger.
- Reishi powder in smoothies/coffee — 1 tsp standardized powder as a daily serving (taste is decidedly bitter, offset with honey/MCT).
- Reishi cocoa (evening) — warm cocoa + 1 tsp reishi powder + coconut milk + honey → magnesium-triterpenoid-theobromine sleep-support trio.
Storage: Dried fruiting body in an airtight jar, in a dark, cool place, stable for 2 years. Powder format 1 year. Liquid extract in the fridge 6 months.
What not to do: Don't cook in aluminum cookware (triterpenoids chelate Al). Don't consume on an empty stomach as a high-dose powder (bitter taste triggers nausea). Don't combine with alcohol or sedatives.
References
[1372] Wachtel-Galor S et al. Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton: CRC Press; 2011. . 2011. Link
Book chapter presenting Ganoderma lucidum (Lingzhi or Reishi) as a medicinal mushroom.
[1373] Cui XY et al. Extract of Ganoderma lucidum prolongs sleep time in rats. J Ethnopharmacol 2012;139(3):796–800. . 2012. Link
ETHNOPHARMACOLOGICAL RELEVANCE: Ganoderma lucidum (Ling Zhi) is a basidiomycete white-rot macrofungus that has been used as a tranquilizing agent (i.e., An-Shen effect) for the treatment of restlessness, insomnia, and palpitation in China for hundreds of years. AIM OF THE STUDY: The present study aimed to investigate whether Ganoderma lucidum extract (GLE) influences the sleep of freely moving rats and the potential mechanism. MATERIALS AND METHODS: Ganoderma lucidum extract was extracted from fruiting bodies of Ganoderma lucidum. Rats were treated with GLE orally for 3 days, and on the third day, electroencephalographic and electromyographic recordings were made for 6h from 9:00 p.m. to 3:00 a.m. in freely moving rats. Sleep parameters were analyzed using SleepSign software. Tumor necrosis factor-α (TNF-α) levels were measured using the enzyme-linked immunosorbent assay.
[1374] Sun LX et al. Polysaccharides from Ganoderma lucidum and immunomodulation. Int J Biol Macromol 2014;65:537–544. . 2014.
Paper on polysaccharides from Ganoderma lucidum and immunomodulation.
[1375] Tang W et al. A randomized, double-blind, placebo-controlled trial of Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food 2005;8(1):53–58. . 2005. Link
Ganoderma lucidum has been widely used to treat various diseases, including cancer, diabetes, and neurasthenia in many Asian countries. This randomized, double-blind, placebo-controlled parallel study aimed to investigate the efficacy and safety of a polysaccharide extract of G. lucidum (Ganopoly) in Chinese patients with neurasthenia. One hundred thirty-two patients with neurasthenia according to the diagnosis criteria of the 10th International Classification of Diseases were included in this study. Written consents were obtained from the patients, and the study was conducted in accordance with Good Clinical Practice guidelines. Patients were randomized to receive Ganopoly or placebo orally at 1,800 mg three times a day for 8 weeks. Efficacy assessments comprised the Clinical Global Impression (CGI) improvement of severity scale and the Visual Analogues Scales for the sense of fatigue and well-being.
[1376] Jin X et al. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev 2016;4:CD007731. . 2016. Link
BACKGROUND: Ganoderma lucidum is a natural medicine that is widely used and recommended by Asian physicians and naturopaths for its supporting effects on immune system. Laboratory research and a handful of preclinical trials have suggested that G. lucidum carries promising anticancer and immunomodulatory properties. The popularity of taking G. lucidum as an alternative medicine has been increasing in cancer patients. However, there is no systematic review that has been conducted to evaluate the actual benefits of G. lucidum in cancer treatment. OBJECTIVES: To evaluate the clinical effects of G. lucidum on long-term survival, tumour response, host immune functions and quality of life in cancer patients, as well as adverse events associated with its use. SEARCH METHODS: We searched an extensive set of databases including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, NIH, AMED, CBM, CNKI, CMCC and VIP Information/Chinese Scientific Journals Database was searched for randomised controlled trials (RCTs) in October 2011.
[1377] Tao J, Feng KY. Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation. J Tongji Med Univ 1990;10(4):240–243. . 1990. Link
Experimental and clinical study of the inhibitory effect of Ganoderma lucidum on platelet aggregation in 15 healthy volunteers and 33 patients with atherosclerotic disease. In vitro, the water-soluble extract dose-dependently inhibited the first and second phases of platelet aggregation; after patients took 1 g three times daily for 2 weeks, ADP-induced aggregation was significantly reduced.
[1378] Wanmuang H et al. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai 2007;90(1):179–181. . 2007.
Case report of fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder.
[1379] Chang CJ et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 2015;6:7489. . 2015. Link
Obesity is associated with low-grade chronic inflammation and intestinal dysbiosis. Ganoderma lucidum is a medicinal mushroom used in traditional Chinese medicine with putative anti-diabetic effects. Here, we show that a water extract of Ganoderma lucidum mycelium (WEGL) reduces body weight, inflammation and insulin resistance in mice fed a high-fat diet (HFD). Our data indicate that WEGL not only reverses HFD-induced gut dysbiosis-as indicated by the decreased Firmicutes-to-Bacteroidetes ratios and endotoxin-bearing Proteobacteria levels-but also maintains intestinal barrier integrity and reduces metabolic endotoxemia. The anti-obesity and microbiota-modulating effects are transmissible via horizontal faeces transfer from WEGL-treated mice to HFD-fed mice. We further show that high molecular weight polysaccharides (>300 kDa) isolated from the WEGL extract produce similar anti-obesity and microbiota-modulating effects.
[1380] Bishop KS et al. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry 2015;114:56–65. . 2000. Link
Medicinal mushrooms have been used for centuries as nutraceuticals to improve health and to treat numerous chronic and infectious diseases. One such mushroom is Ganoderma lucidum, commonly known as Lingzhi, a species revered as a medicinal mushroom for treating assorted diseases and prolonging life. The fungus is found in diverse locations, and this may have contributed to confusion regarding the correct taxonomic classification of the genus Ganoderma. G. lucidum was first used to name a specimen found in England and thereafter was naively applied to a different Ganoderma species found in Asia, commonly known as Chinese Lingzhi. Despite the taxonomic confusion, which has largely been uncorrected, the popularity of Lingzhi has escalated across the globe. The current taxonomic situation is now discussed accurately in this Special Issue on Ganoderma.